A groundbreaking study is underway to understand why some people with aggressive cancers, like lung or brain cancer, survive much longer than predicted.
Researchers are studying the biological factors in 'super-survivors'—examining their DNA, immune systems, and tumor characteristics—to find answers.
The hope is to identify vulnerabilities in these aggressive cancers, paving the way for the development of innovative treatments.
This research holds the potential for significantly improving outcomes for patients battling difficult-to-treat cancers globally.
